Advisory Services Network’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.28M Buy
100,315
+36,279
+57% +$1.97M 0.05% 404
2026
Q1
$4.02M Buy
64,036
+24,579
+62% +$1.97M 0.05% 384
2025
Q4
$3.76M Buy
39,457
+2,072
+6% +$203K 0.05% 389
2025
Q3
$3.65M Buy
37,385
+3,289
+10% +$341K 0.05% 380
2025
Q2
$3.58M Buy
34,096
+2,812
+9% +$285K 0.06% 359
2025
Q1
$3.16M Sell
31,284
-14,850
-32% -$1.5M 0.06% 363
2024
Q4
$4.12M Sell
46,134
-3,616
-7% -$318K 0.08% 296
2024
Q3
$3.83M Hold
49,750
0.08% 275
2024
Q2
$3.83M Buy
49,750
+5,822
+13% +$426K 0.08% 275
2024
Q1
$3.01M Sell
43,928
-5,470
-11% -$352K 0.07% 345
2023
Q4
$2.86M Buy
49,398
+2,362
+5% +$126K 0.07% 321
2023
Q3
$2.48M Buy
47,036
+1,853
+4% +$97.2K 0.07% 341
2023
Q2
$2.44M Buy
45,183
+35,319
+358% +$1.84M 0.07% 348
2023
Q1
$493K Buy
9,864
+286
+3% +$13.5K 0.01% 913
2022
Q4
$443K Sell
9,578
-3,695
-28% -$160K 0.01% 909
2022
Q3
$515K Sell
13,273
-4,052
-23% -$163K 0.02% 789
2022
Q2
$647K Sell
17,325
-962
-5% -$39.2K 0.02% 719
2022
Q1
$811K Buy
18,287
+10,835
+145% +$470K 0.02% 699
2021
Q4
$317K Sell
7,452
-4,158
-36% -$175K 0.01% 1099
2021
Q3
$504K Buy
11,610
+404
+4% +$17.9K 0.02% 868
2021
Q2
$479K Buy
11,206
+452
+4% +$19K 0.02% 899
2021
Q1
$416K Buy
10,754
+3,497
+48% +$132K 0.02% 905
2020
Q4
$261K Sell
7,257
-239
-3% -$8.61K 0.01% 967
2020
Q3
$287K Buy
7,496
+1,621
+28% +$62.5K 0.01% 844
2020
Q2
$206K Buy
5,875
+140
+2% +$5.04K 0.01% 930
2020
Q1
$187K Sell
5,735
-3,932
-41% -$154K 0.01% 847
2019
Q4
$438K Buy
9,667
+775
+9% +$32.4K 0.02% 658
2019
Q3
$382K Hold
8,892
0.02% 627
2019
Q2
$382K Buy
8,892
+869
+11% +$33.4K 0.02% 625
2019
Q1
$308K Buy
8,023
+6,122
+322% +$234K 0.02% 655
2018
Q4
$67K Sell
1,901
-15,723
-89% -$570K 0.01% 1032
2018
Q3
$678K Buy
17,624
+15,819
+876% +$553K 0.05% 448
2018
Q2
$62K Buy
1,805
+907
+101% +$27.4K ﹤0.01% 1131
2018
Q1
$25K Sell
898
-65
-7% -$1.77K ﹤0.01% 1568
2017
Q4
$24K Sell
963
-39
-4% -$1.08K ﹤0.01% 1556
2017
Q3
$29K Hold
1,002
﹤0.01% 1284
2017
Q2
$28K Buy
1,002
+649
+184% +$17.2K ﹤0.01% 1224
2017
Q1
$9K Buy
+353
New +$8.58K ﹤0.01% 1498
2016
Q3
$5K Sell
210
-306
-59% -$7.3K ﹤0.01% 1508
2016
Q2
$12K Buy
516
+256
+98% +$5.54K ﹤0.01% 1152
2016
Q1
$5K Sell
260
-122
-32% -$2.14K ﹤0.01% 1250
2015
Q4
$7K Buy
382
+260
+213% +$4.66K ﹤0.01% 1021
2015
Q3
$2K Hold
122
﹤0.01% 1317
2015
Q2
$2K Hold
122
﹤0.01% 1259
2015
Q1
$2K Hold
122
﹤0.01% 1175
2014
Q4
$2K Buy
+122
New +$1.56K ﹤0.01% 1080
2014
Q1
Sell
-122
Closed -$1K 272
2013
Q4
$1K Buy
+122
New +$1.44K ﹤0.01% 1037

Other funds holding BSX

Advisory Services Network's BSX Position: Q2 2026 in Review

Advisory Services Network increased its Boston Scientific (BSX) stake by 57% in Q2 2026, buying an estimated $1.97M and bringing the position to 100,315 shares worth $4.28M. The position accounts for 0.05% of the portfolio, ranked #404.

Advisory Services Network first reported a position in BSX in Q4 2013 and has held it in 47 quarters since. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Advisory Services Network held 100,315 shares of Boston Scientific worth $4.28M as of Q2 2026.
  • Advisory Services Network bought 36,279 Boston Scientific shares in Q2 2026, an estimated $1.97M.
  • Boston Scientific made up 0.05% of Advisory Services Network's portfolio in Q2 2026, its #404 holding.
  • Advisory Services Network first reported a position in Boston Scientific in Q4 2013 and has held it in 47 quarters since.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.